Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
NCT00788528
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
766
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
S-2367 (velneperit)
Sponsor
Shionogi